Adjusted relative risks reduced for non-COVID-19 mortality after receipt of Pfizer-BioNTech, Moderna, Janssen vaccines
Statins May Be Tied to Lower Risk for COVID-19 Death
Statin treatment tied to moderately lower COVID-19 mortality in large population study accounting for preexisting health conditions and other factors
Geriatrics-Focused Risk Factors ID’d for COVID-19 Death
Indicators other than age alone can be used to determine prognosis in older adults hospitalized with COVID-19
High Mortality for Psych Disorders Worse During the Pandemic
COVID-19 standardized mortality rates were elevated across nine psychiatric conditions including learning disabilities, eating disorders
Convalescent Plasma Unlikely to Improve Outcomes in Severe COVID-19
Likelihood of improvement in organ support-free days low in critically ill adults with COVID-19 receiving convalescent plasma
Obesity May Up Length of Stay, Mortality for COVID-19 Patients in ICU
Twofold higher risk for composite outcome of death or length of stay ≥14 days seen in obese COVID-19 patients admitted to the ICU
>140,000 U.S. Children Have Been Orphaned by COVID-19
Risk for loss was 1.1 to 4.5 times higher among children of racial/ethnic minorities compared with non-Hispanic Whites
Outpatient Anticoagulant Therapy May Cut COVID-19 Admission Risk
COVID-19 inpatients not on anticoagulants before or after hospitalization have increased risk for mortality
Racial/Ethnic Disparities in Excess Mortality Up During Pandemic
Black, American Indian/Alaska Native, Latino persons also disproportionately affected by non-COVID-19 excess deaths
U.S. Nursing Home Deaths Rise as Delta Spreads
American Health Care Association says infections are largely the result of a high number of cases in the surrounding community